T Etgen1, M Mühlau, C Gaser, D Sander. 1. Department of Neurology, Technische Universität München, München, Germany. thorleif.etgen@klinikum-traunstein.de
Abstract
BACKGROUND: Primary blepharospasm is a focal dystonia characterised by excessive involuntary closure of the eyelids. The pathophysiology of primary blepharospasm is unresolved. AIM: To pinpoint grey-matter changes that are associated with primary blepharospasm. METHODS: 16 right-handed patients with primary blepharospasm (mean age 67.4 (SD 4.3) years; 12 women) were compared with 16 healthy volunteers matched for sex and age. High-resolution T1-weighted magnetic resonance imaging of each participant was obtained and analysed by voxel-based morphometry, a method to detect regionally specific differences in grey matter between patients and control group. To evaluate whether the identified grey-matter changes were correlated with the duration of primary blepharospasm or botulinum neurotoxin treatment (BoNT), separate regression analyses were carried out. RESULTS: In patients with primary blepharospasm, grey-matter increase in the putamina was observed, whereas regression analyses did not indicate a correlation between grey-matter increases and the duration of primary blepharospasm or BoNT. Grey-matter decrease was detected in the left inferior parietal lobule; here regression analyses of grey-matter decrease showed a significant (p = 0.013) correlation of grey-matter decrease with the duration of BoNT. CONCLUSIONS: The data suggest structural changes in primary blepharospasm and point to a crucial role of the putamen for the pathophysiology of this focal dystonia.
BACKGROUND:Primary blepharospasm is a focal dystonia characterised by excessive involuntary closure of the eyelids. The pathophysiology of primary blepharospasm is unresolved. AIM: To pinpoint grey-matter changes that are associated with primary blepharospasm. METHODS: 16 right-handed patients with primary blepharospasm (mean age 67.4 (SD 4.3) years; 12 women) were compared with 16 healthy volunteers matched for sex and age. High-resolution T1-weighted magnetic resonance imaging of each participant was obtained and analysed by voxel-based morphometry, a method to detect regionally specific differences in grey matter between patients and control group. To evaluate whether the identified grey-matter changes were correlated with the duration of primary blepharospasm or botulinum neurotoxin treatment (BoNT), separate regression analyses were carried out. RESULTS: In patients with primary blepharospasm, grey-matter increase in the putamina was observed, whereas regression analyses did not indicate a correlation between grey-matter increases and the duration of primary blepharospasm or BoNT. Grey-matter decrease was detected in the left inferior parietal lobule; here regression analyses of grey-matter decrease showed a significant (p = 0.013) correlation of grey-matter decrease with the duration of BoNT. CONCLUSIONS: The data suggest structural changes in primary blepharospasm and point to a crucial role of the putamen for the pathophysiology of this focal dystonia.
Authors: Mark Mühlau; Joachim Hermsdörfer; Georg Goldenberg; Afra M Wohlschläger; Florian Castrop; Robert Stahl; Michael Röttinger; Peter Erhard; Bernhard Haslinger; Andres O Ceballos-Baumann; Bastian Conrad; Henning Boecker Journal: Neuropsychologia Date: 2005-01-05 Impact factor: 3.139
Authors: M Hutchinson; T Nakamura; J R Moeller; A Antonini; A Belakhlef; V Dhawan; D Eidelberg Journal: Neurology Date: 2000-09-12 Impact factor: 9.910
Authors: Richard A Walsh; Robert Whelan; John O'Dwyer; Sean O'Riordan; Siobhan Hutchinson; Risteard O'Laoide; Kevin Malone; Richard Reilly; Michael Hutchinson Journal: J Neurol Date: 2009-04-08 Impact factor: 4.849
Authors: B Draganski; S A Schneider; M Fiorio; S Klöppel; M Gambarin; M Tinazzi; J Ashburner; K P Bhatia; R S J Frackowiak Journal: Neuroimage Date: 2009-04-01 Impact factor: 6.556
Authors: Samuel R Chamberlain; Lara A Menzies; Naomi A Fineberg; Natalia Del Campo; John Suckling; Kevin Craig; Ulrich Müller; Trevor W Robbins; Edward T Bullmore; Barbara J Sahakian Journal: Br J Psychiatry Date: 2008-09 Impact factor: 9.319